SmarterDX
SmarterDx provides a proprietary clinical AI platform that aligns hospital financial ecosystems by automating documentation, reimbursement, and denial management to maximize revenue capture.
Classification
Profile
Funding
Funding details not yet available.
Aligns hospital financial ecosystems via proprietary clinical AI to capture revenue, automate denials, and ensure accurate reimbursement by telling the complete patient story.
Health systems and hospitals seeking to optimize revenue cycle management and clinical documentation accuracy.
SaaS/services for hospital-wide AI platform deployment.
Direct sales to health systems via enterprise contracts.
EHR Vendors (Epic, Cerner, Meditech) - deep integration points and co-marketing · Revenue Cycle Management Companies - joint go-to-market bundles (e.g., RCM outsourcing firms) · Academic Medical Centers - research collaborations for model validation and publishing
R&D for clinical AI, sales team, and hospital integration logistics.
Proprietary clinical AI technology and a trusted network of over 85 health systems.
Reviewing 100% of patient charts, capturing revenue opportunities, appealing denials, and inserting revenue cycle intelligence.
Sales-led with ongoing support to maintain hospital partnerships.
Competes in clinical AI for revenue cycle management; differentiates by aligning documentation to reimbursement and reviewing 100% of charts.
Incomplete patient documentation leading to lost revenue, high denial rates, and inefficient revenue cycle operations.
Expand beyond direct sales by leveraging academic partnerships for third-party validation to accelerate enterprise trust and reduce long sales cycles.
The combination of proprietary AI and deep EHR integration creates a high switching cost moat, locking in health systems through workflow dependency.
Key partnerships with EHR vendors enable the direct sales channel by providing trusted integration points, while the 85-health-system network validates the value proposition for new prospects.
The $2 M net new revenue per 10 k discharges claim is corroborated by multiple press releases and investor decks, indicating a realistic ROI · The physician-led AI development approach is validated by the company’s leadership (MD founder, clinical data scientists) and aligns with em · Recent $50 M Series B funding (2025) from reputable venture firm
Team details not yet available.
No investors recorded yet.